Detalhe da pesquisa
1.
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Lancet Oncol
; 21(8): 1066-1076, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653053
2.
Nivolumab plus ipilimumab in advanced melanoma.
N Engl J Med
; 369(2): 122-33, 2013 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23724867
3.
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
N Engl J Med
; 366(26): 2455-65, 2012 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22658128
4.
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
N Engl J Med
; 366(26): 2443-54, 2012 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22658127
5.
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab.
J Clin Oncol
; 41(5): 943-954, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36750016
6.
High-throughput molecular and histopathologic profiling of tumor tissue in a novel transplantable model of murine neuroblastoma: new tools for pediatric drug discovery.
Cancer Invest
; 30(5): 343-63, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22571338
7.
Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages.
Immunology
; 132(2): 226-39, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21039467
8.
Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow.
J Immunol
; 182(7): 4328-38, 2009 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19299733
9.
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response.
J Immunother Cancer
; 8(1)2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32385146
10.
Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology.
J Transl Med
; 7: 45, 2009 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19534815
11.
A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".
J Transl Med
; 6: 81, 2008 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-19105846
12.
Combination immunotherapy: a road map.
J Immunother Cancer
; 5: 16, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28239469
13.
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.
J Immunother Cancer
; 5: 44, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28515944
14.
Pediatric pancreatoblastoma: histopathologic and cytogenetic characterization of tumor and derived cell line.
Cancer Genet Cytogenet
; 157(2): 109-17, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15721631
15.
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
Clin Cancer Res
; 9(15): 5442-53, 2003 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14654523
16.
Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab.
J Clin Oncol
; 33(18): 2013-20, 2015 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25800770
17.
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
J Clin Oncol
; 33(18): 2004-12, 2015 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25897158
18.
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.
J Immunother Cancer
; 8(1)2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32300051
19.
IL-12/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedside.
Expert Opin Biol Ther
; 2(5): 513-24, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12079487
20.
Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitor.
Cancer Immunol Res
; 2(1): 70-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24416731